Cargando…

A lymphatic co-culture model for personalized cancer medicine

Detalles Bibliográficos
Autores principales:	Kolarzyk, Anna M., Lee, Esak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581250/ https://www.ncbi.nlm.nih.gov/pubmed/34753105 http://dx.doi.org/10.1016/j.ebiom.2021.103685

Ejemplares similares

Lymphatic endothelial cells support tumor growth in breast cancer
por: Lee, Esak, et al.
Publicado: (2014)

Blood and Lymphatic Vasculatures On-Chip Platforms and Their Applications for Organ-Specific In Vitro Modeling
por: Henderson, Aria R., et al.
Publicado: (2020)

Prostate Cancer Claims for a Personalized Medicine
por: Lazzeri, Massimo
Publicado: (2015)

Predictive Modeling of Drug Treatment in the Area of Personalized Medicine
por: Ogilvie, Lesley A., et al.
Publicado: (2015)

Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
por: Lee, Esak, et al.
Publicado: (2014)

Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
por: Noordegraaf, Marina A., et al.
Publicado: (2023)

Lymphatic Vessels as Targets of Tumor Therapy?
por: Karpanen, Terhi, et al.
Publicado: (2001)

Recent advances in 3D bioprinted tumor models for personalized medicine
por: Gnatowski, Przemysław, et al.
Publicado: (2023)

Towards personalized medicine – the role of methotrexate
por: Naik, Sita
Publicado: (2011)

Metabolomics: moving towards personalized medicine
por: Baraldi, Eugenio, et al.
Publicado: (2009)

Solid Cancer Treatment With Aurora Kinase Inhibitors: Towards a Personalized Medicine
por: Ulisse, Salvatore
Publicado: (2017)

Personomics: The Missing Link in the Evolution from Precision Medicine to Personalized Medicine
por: Ziegelstein, Roy C.
Publicado: (2017)

Additional Refinement of CKD Prognostication Using Lymphatic Vessel Density: IgA Nephropathy as the Role Model?
por: Kronbichler, Andreas, et al.
Publicado: (2022)

Personalized Nursing Care in Precision-Medicine Era
por: Lopes-Júnior, Luís Carlos
Publicado: (2021)

Ethics, Evidence and Economics in the Pursuit of “Personalized Medicine”
por: Lewis, Jan, et al.
Publicado: (2014)

The Formation of Lymphatic Vessels and Its Importance in the Setting of Malignancy
por: Detmar, Michael, et al.
Publicado: (2002)

The Canadian Path from Discovery to Implementation of Personalized Medicine Approaches
por: Richer, Étienne, et al.
Publicado: (2017)

Personalized signaling models for personalized treatments
por: Saez‐Rodriguez, Julio, et al.
Publicado: (2020)

Personalized medicine and allergen immunotherapy: the beginning of a new era?
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Gene patents and personalized medicine - what lies ahead?
por: Chandrasekharan, Subhashini, et al.
Publicado: (2009)

Integrating functional genomics to accelerate mechanistic personalized medicine
por: Tyner, Jeffrey W.
Publicado: (2017)

An organoids biobank for recapitulating tumor heterogeneity and personalized medicine
por: Yang, Hui, et al.
Publicado: (2020)

Imaging Early Pathogenesis of Bubonic Plague: Are Neutrophils Commandeered for Lymphatic Transport of Bacteria?
por: Bland, David M., et al.
Publicado: (2013)

Application of Decision-Analytic Models in Personalized Medicine for CML Treatment Decisions Made by Payers, Providers, and Patients
por: Saverno, Kim R., et al.
Publicado: (2012)

Commentary: Fontan circulation with lymphatic failure: Was the Holy Grail finally found?
por: Sandica, Eugen
Publicado: (2021)

Under pressure: Ano1 mediates pressure sensing in the lymphatic system
por: Tembo, Maiwase, et al.
Publicado: (2019)

Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine
por: Lamy, Pierre-Jean, et al.
Publicado: (2012)

Can ADAMTS13 Lead Us to the Paradise of Personalized Medicine?
por: Rossing, Peter, et al.
Publicado: (2013)

The personalized medicine for pancreatic ductal adenocarcinoma patients: The oncologist perspective
por: Peretti, Umberto, et al.
Publicado: (2017)

Commentary: Personalized medicine for genetically triggered thoracic aortic aneurysms
por: Arnaoutakis, George J., et al.
Publicado: (2020)

Subphenotyping of critical illness: where protocolized and personalized intensive care medicine meet
por: Ramos, Fernando José da Silva, et al.
Publicado: (2022)

New lumefantrine self nanoemulsifying delivery system – will it by-pass lymphatic transport mechanisms?
por: Srinivas, Nuggehally R
Publicado: (2013)

Personalizing Medicine and Technologies to Address the Experiences and Needs of People with Multiple Sclerosis
por: Henschke, Adam, et al.
Publicado: (2021)

Towards personalized medicine in preterm newborns: Morphine analgesia predicted by genotype
por: Simons, Sinno.H.P.
Publicado: (2019)

Conditional reprogramming technology: a new tool for personalized medicine in bladder cancer?
por: Miyamoto, Hiroshi
Publicado: (2019)

Personalized Computational Models as Biomarkers
por: Kolch, Walter, et al.
Publicado: (2017)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

The Importance of Understanding Social and Cultural Norms in Delivering Quality Health Care—A Personal Experience Commentary
por: Latif, Ahmed S.
Publicado: (2020)

Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine
por: Calzetta, Luigino, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1qf2afs6lbihuc4jchem1cvvhj